1-7 of 7
Jonathan W. Said, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASXL2 Is Recurrently Mutated in t(8;21) AML and Regulates Hematopoietic Development

Vikas Madan, PhD, Lin Han, Norimichi Hattori, MD, Anand Mayakonda, Qiao-Yang Sun, PhD, Ling-Wen Ding, PhD, Hazimah Binte Mohd Nordin, Su Lin Lim, Weoi Woon Teoh, Pavithra Shyamsunder, Janani Sundaresan, Ngan B. Doan, Masashi Sanada, MD PhD, Aiko Sato-Otsubo, Li-Zhen Liu, Henry Yang, Jonathan W. Said, MD, Seishi Ogawa, MD PhD, Der-Cherng Liang, MD, Lee-Yung Shih, MD, Tsuyoshi Nakamaki, MD, Q. Tian Wang, H. Phillip Koeffler, MD
Journal: Blood
Blood (2016) 128 (22): 1051.
https://doi.org/10.1182/blood.V128.22.1051.1051
Published: 2016
Journal Articles

Analysis of Programmed Death Ligand 1 (PD-L1) Expression in Diffuse Large B Cell Lymphomas (DLBCL) in HIV-Negative Versus HIV-Positive Patients

Chun Chao, PhD, Patricia A Young, MD, Lanfang Xu, PhD, Michael J. Silverberg, PhD MPH, Jonathan W. Said, MD, John M. Timmerman, MD
Journal: Blood
Blood (2015) 126 (23): 1462.
https://doi.org/10.1182/blood.V126.23.1462.1462
Published: 2015
Journal Articles

Circadian Clock Protein CRY Controls B-Cell Intrinsic Tolerance

Qi Cao, doctor, Xuan Zhao, Doctor, Sigal Gery, Doctor, Zhengshan Chen, PhDMD, Ruishu Deng, MD PhD, Haibo Sun, Doctor, De-chen Lin, Doctor, Zhiqiang Zhao, Doctor, Jonathan W Said, MD, Quan-zhen Li, Doctor, Markus Muschen, MDPhD, Ronald M. Evans, PhD, H. Phillip Koeffler, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1029.
https://doi.org/10.1182/blood.V126.23.1029.1029
Published: 2015
Journal Articles

Interfollicular CD10 Expression and Follicular PD1 Tumor-Infiltrating Lymphocytes As Biologic Risk Factors in Patients with Previously Untreated Follicular Lymphoma Receiving Rituximab-Based Biologic Therapy: An Alliance Correlative Science Study (CALGB 50901, 50402, 50701, 50803, 50401)

Aliyah R Sohani, MD, Brandy Pitcher, MS, Amy Chadburn, MD, Jonathan W. Said, MD, Peter Martin, MD, Myron S. Czuczman, MD, Nancy L Bartlett, MD, Cara A. Rosenbaum, MD, John P. Leonard, MD, Bruce D. Cheson, MD, Eric D. Hsi, MD
Journal: Blood
Blood (2015) 126 (23): 334.
https://doi.org/10.1182/blood.V126.23.334.334
Published: 2015
Journal Articles

CEBPalpha and a Critical Circadian Clock Downstream Target Gene, PER2 , Are Highly Dysregulated in Diffuse Large B-Cell Lymphoma.

Nils Heinrich Thoennissen, MD, Gabriela B. Iwanski, MD, BaoNgan Doan, Sigal Gery, PhD, Jonathan W Said, MD, H. Phillip Koeffler, MD
Journal: Blood
Blood (2009) 114 (22): 3454.
https://doi.org/10.1182/blood.V114.22.3454.3454
Published: 2009
Journal Articles

The PIM1 Oncogene Accelerates TCL1 Driven Lymphomagenesis in a Double-Transgenic Murine Model.

Matthew I. Schrage, PhD, David Kim, MD, Jeffrey Calimlim, Evelena Ontiveros, MD, PhD, Michael A. Teitell, MD, PhD, Jonathan W. Said, MD, Sven de Vos, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1806.
https://doi.org/10.1182/blood.V112.11.1806.1806
Published: 2008
Journal Articles

Active Combination Therapy of Bortezomib (Velcade) and Ibritumomab Tiuxetan (Zevalin) in an In Vivo Diffuse Large B-Cell Lymphoma Model.

Milena Pervan, PhD, Jeffrey Calimlim, Dan Matso, PharmD, Jonathan W. Said, MD, William H. McBride, PhD, Sven de Vos, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2406.
https://doi.org/10.1182/blood.V106.11.2406.2406
Published: 2005